Avraham Pharmaceuticals avphar.com

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 for Alzheimer's disease. Ladostigil is a multifunctional compound that combines proven anti-symptomatic mechanisms of action with neuroprotective mechanisms, and was designed to provide durable, broad symptomatic treatment outcomes and disease-modification.

Avraham Pharmaceuticals is a pharmaceutical company developing products for treatment and/or prevention of neurodegenerative disorders. The company's lead product candidate, ladostigil, is in Phase 2 for Alzheimer's disease. Ladostigil is a multifunc...Show all

Company (Alive / Active)

All investors data 6 Investors

• Clal Biotechnology Industries
• Integra Holdings
• Pontifax
• Prof. Marta Weinstock-Rosin
• Technion Research & Development Foundation

Board Members

Competitors

Patents